USD
EUR
GBP
CAD
AUD
CHF
HKD
JPY
RUB
BRL
CLP
NOK
DKK
SEK
KRW
ILS
MXN
CNY
SAR
SGD
NZD
ARS
INR
COP
AED
Home
Products
Peptides
Nootropics
Steriods
Sarms
Custom synthesis
Others
About Us
About Us
Sitemap
FAQ
Blog
News
Download
Contact Us
0
Home
Products
Peptides
Nootropics
Steriods
Sarms
Custom synthesis
Others
About Us
About Us
Sitemap
FAQ
Blog
News
Download
Contact Us
Home
>
News
News
sarms4muscle- oxiracetam ,piracetampowder products video
May 05, 2023
05-05
2023
New Small Molecule Drugs Approved by FDA in 2023Q1 and Drug Design Ideas
May 05, 2023
05-05
2023
New Small Molecule Drugs Approved by FDA in 2023Q1 and Drug Design Ideas
Brenzavvy (bexagliflozin)
Jayprica (Pirtobrutinib)
Orserdu (elacestrant)
Jesduvroq (daprodustat)
Filspari (sparsentan)
Skyclarys (omaveloxolone)
Zavzpret (zavegepant)
Daybue (trofinetide)
Rezzayo (rezafungin)
Joenja (leniolisib)
The Science Behind Aniracetam Capsules and Their Effects on the Brain
Apr 27, 2023
04-27
2023
JAK/HDAC bispecific inhibitor developed to be efficient against solid tumors and malignant leukemia
Apr 26, 2023
04-26
2023
JAK/HDAC bispecific inhibitor developed to be efficient against solid tumors and malignant leukemia
CBD replaces opioids for chronic pain
Apr 25, 2023
04-25
2023
The global medical cannabis market is expanding, and the treatment of chronic pain generates a large enough volume and demand for CBD products.
The epilepsy treatment drug: Cenobamate
Apr 24, 2023
04-24
2023
Chemical Name: Cenobamate
CAS No.: 913088-80-9
DAYBUE (Trofinetide) Approved by the FDA, Expected to Be Available at the End of Next Month.
Mar 31, 2023
03-31
2023
DAYBUE (trofinetide CAS 853400-76-7) approved by the FDA, expected to be available at the end of next month.
Rett, commonly known as Rett syndrome, is one of the most common genetic causes of severe mental impairment in the world.
Trofinetide is a new IGF-1 amino-terminal tripeptide analogue that is being developed to treat the main symptoms of Rett syndrome by lowering neuroinflammation and promoting synaptic function.
"Myopia Cure" - Are Low Concentration Atropine Eye Drops Effective?
Mar 31, 2023
03-31
2023
"Myopia Cure" - Are Low Concentration Atropine(CAS 51-55-8) Eye Drops Effective?
I. Substantially delay the progression of myopia
2. high level of security
3. Easy to use
4. Low cost
Pfizer's New Nasal Spray for Acute Migraine Treatment Approved by the FDA
Mar 31, 2023
03-31
2023
ZAVEGEPANT (ZAVZPRET) CAS: 1337918-83-8
Pfizer's New Nasal Spray for Acute Migraine Treatment Approved by the FDA
Pfizer conducted a two-line phase III trial to demonstrate the safety and efficacy of this product in order to obtain FDA approval.
The Benefits of Piracetam: Improving Memory and Focus
Mar 31, 2023
03-31
2023
1
2
3
4
5
6
7
page:
Go